AzTrials
AzTrials

PsychosisCSCPIINCT03465371

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care

A study testing CSC OnDemand Training Intervention, InPerson Intervention and Virtual InPerson Intervention in people with Psychosis, run by Center for Social Innovation, Massachusetts at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Psychosis
What is being tested?
CSC OnDemand Training Intervention, InPerson Intervention and Virtual InPerson Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
349 participants
Where
1 siteUnited States
Study dates
1 Oct 2018to 31 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Agencies will need to provide:
  • direct care to individuals with early psychosis;
  • administrative-level support for training and use of the CSC model;
  • an entire treatment team that is willing to participate in this team-based intervention;
  • contact information for direct service staff;
  • support for the study, including a staff person to serve as a liaison to work with the research team;
  • access to the Internet during the intervention period; and
  • a willingness to provide data and participate in the evaluation.

Who cannot join

  • Teams should not have previously received CSC training.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Center for Social Innovation

    Needham, Massachusetts, 02494

Other trials in United States

About this study

In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care. The product builds on the findings of the Recovery After an Initial Schizophrenia Episode (RAISE) studies, funded by the National Institute of Mental Health (NIMH). RAISE examined team-based models of care for people early in the course of schizophrenia. Through a Fast Track Small Business Innovation Research (SBIR) grant, investigators will prototype, test, refine, and evaluate the impact of CSC OnDemand.

Read the detailed description

Building on existing resources and the expertise of our faculty and advisors, the investigators developed CSC OnDemand, a multifaceted online learning product that includes four levels: 1) an online readiness tool and CSC Learning Hub; 2) dynamic multimedia core curriculum on first episode psychosis and CSC; 3) live faculty-led online courses; and 4) ongoing support, including an online community of practice to support peer-to-peer learning.

During Phases I and II of this Fast Track SBIR, the investigators prototyped, pilot tested, built out, and evaluated the product through a cluster randomized study comparing it with InPerson training (and due to the global pandemic, a "virtual" in person training, using Zoom to train with the same curriculum as in-person, creating (unexpectedly) three study arms).

Phase I built a robust prototype of the online platform and tested it with 16 providers from three sites. This phase explored feasibility, acceptability, and preliminary effectiveness of the product, and examined which components of the online platform providers found most useful.

Based on our findings from Phase I, the investigators refined and fully built out the product to test in a larger randomized trial. Phase II used a cluster randomized non-inferiority design to assess if OnDemand training (n = 20 sites) was comparable to InPerson training (n = 10 sites). Using a mixed-methods approach, the investigators examined provider (n enrolled was 239; after attrition 206) outcomes (satisfaction; knowledge gains/retention; attitudes toward shared decision making) and client (n = 110) outcomes (work/school participation; engagement in CSC services; inpatient psychiatric hospitalizations).

The study was guided by the following specific aims:

Phase II AIM 1: To refine, expand, and finalize CSC OnDemand based on Phase I findings.

AIM 2: To examine the differences in outcomes of OnDemand training intervention as compared to the InPerson and Virtual In Person interventions as it related to CSC providers knowledge and shared decision making (SDM). Hypothesis: Providers in the OnDemand condition will achieve increases in knowledge, SDM and satisfaction at post training and nine months that will be no more than .5 standard deviations less than the InPerson or Virtual InPerson condition.

AIM 3: To determine if the OnDemand training intervention is as successful as the InPerson or Virtual InPerson training in increasing participation in work or school, improving engagement in treatment, and decreasing relapse rates for participating clients. Hypothesis: Clients being served by the providers in the OnDemand condition will have work/school participation rates, levels of engagement and rates of hospitalization nine months after admission that are no more than 10 percent higher (hospitalization) or lower (work/school, engagement) than clients served by providers in the InPerson or Virtual InPerson condition.

Conditions
Psychosis
Being tested
CSC OnDemand Training Intervention, InPerson Intervention, Virtual InPerson Intervention
Medical subject headings
Psychotic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CSC OnDemand Training InterventionOther

    Level 1: Readiness

    Online readiness tool

    Level 2: Core Knowledge

    Week 1-self-paced core curriculum, totaling 8 hours of instruction

    Level 3: Going Deeper

    Week 2-instructor-led, role-specific, and advanced topics, totaling 12 hours of instruction

    Level 4: Sustainability

    9 months of online community of practice support; a discussion forum; open office hours with experts; multisite case conferencing; access to online materials

  • InPerson InterventionOther

    Level 1: Readiness

    Telephone conversations with program leaders to determine structures, roles, staffing, recruitment

    Level 2: Core Knowledge

    1 day of in-person training on FEP basics and CSC components

    Level 3: Going Deeper

    1.5 days of in-person training on how the team works, followed by breakout sessions by role

    Level 4: Sustainability

    9 months of monthly implementation coaching calls with team leads; monthly telephone case conferences; monthly care coordination calls split out by role

  • Virtual InPerson InterventionOther

    Level 1: Readiness

    Telephone conversations with program leaders to determine structures, roles, staffing, recruitment

    Level 2: Core Knowledge

    1 day of virtual (via Zoom) in-person training on FEP basics and CSC components

    Level 3: Going Deeper

    1.5 days of virtual (via Zoom) in-person training on how the team works, followed by breakout sessions by role

    Level 4: Sustainability

    9 months of monthly implementation coaching calls with team leads; monthly telephone case conferences; monthly care coordination calls split out by role

Study groups in NCT03465371
Study groupRoleWhat they receive
OnDemand Training InterventionExperimentalParticipants receiving the OnDemand Training Intervention
Receives: Other: CSC OnDemand Training Intervention
InPerson InterventionActive comparatorParticipants receiving the InPerson Intervention
Receives: Other: InPerson Intervention
Virtual InPerson InterventionActive comparatorParticipants receiving the Virtual InPerson Intervention (the InPerson training via Zoom)
Receives: Other: Virtual InPerson Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Provider-level: Success in increasing CSC providers knowledge of CSC

    CSC knowledge will be assessed with a 50-item, complex, multiple-choice test (25 common across disciplines, 25 discipline-specific), which will be created in conjunction with the intervention modules and will be piloted in Phase I. The outcome will be the percentage of correct responses.

    Measured: Up to 9 months

  2. Provider-level: Success in increasing CSC providers shared decision making

    Shared Decision Making Questionnaire-physician version (SDM-Q-Doc) is a standardized brief instrument (9 items) for assessing SDM in clinical encounters. SDM-Q-Doc was developed for physicians, but has been adapted to all healthcare professionals. The instrument consists of 9 statements rated on a 6-point scale from "completely disagree" (0) to "completely agree" (5). The items are summed to create a total score.

    Measured: Up to 9 months

Secondary outcomes (3)
  1. Client-level: Work/School Participation

    Work/school participation (any work or school participation in the prior three months) will be assessed by the team at baseline, three months, six months, and nine months.

    Measured: Up to 9 months

  2. Client-level: Engagement

    The time to last mental health visit will be truncated at the nine-month point, so the investigators will use a binary indicator (yes/no) of continued treatment participation at nine months.

    Measured: Up to 9 months

  3. Client-level: Psychiatric Hospitalization

    The investigators will use a binary indicator of whether the client has been hospitalized in the first nine months of treatment.

    Measured: Up to 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2018
  2. Study start1 Oct 2018
  3. Primary completion31 Jan 2022
  4. Study completion31 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A 3-arm randomized controlled trial
Masking
None (open label)
Enrolment
349 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03465371
Sponsor's protocol ID
4R44MH111283-02
Acronym
CSCPII
Status last verified
Apr 2022
First submitted
20 Feb 2018
Last updated
2 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing CSC OnDemand Training Intervention, InPerson Intervention and Virtual InPerson Intervention in people with Psychosis, run by Center for Social Innovation, Massachusetts at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Provider-level: Success in increasing CSC providers knowledge of CSC (time frame: Up to 9 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in